Mereo BioPharma Group

NASDAQ: MREO · Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.74
0.00%
After-hours: Aug 15, 2025, 06:25 PM EDT

Mereo BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
69.8M 57.42M 56.33M 94.3M
Short-Term Investments
n/a n/a 51.1M 569K
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -25.95M -27.09M
Receivables
3.25M 3.73M 2.75M 1.42M
Inventory
n/a n/a -2.67M -1.82M
Other Current Assets
507K 1.98M 1.43M 2.23M
Total Current Assets
74.76M 63.76M 62.13M 99.32M
Property-Plant & Equipment
984K 1.65M 1.83M 2.53M
Goodwill & Intangibles
643K 1.09M 24.12M 24.56M
Total Long-Term Assets
1.63M 2.74M 25.95M 27.09M
Total Assets
76.39M 66.5M 88.08M 126.42M
Account Payables
2.44M 2.35M 3.49M 2.29M
Deferred Revenue
n/a n/a n/a 8.37M
Short-Term Debt
5.54M n/a 11.02M n/a
Other Current Liabilities
2.87M 2.37M 5.82M 5.62M
Total Current Liabilities
13.85M 9.49M 24.68M 12.54M
Long-Term Debt
n/a 4.39M n/a n/a
Other Long-Term Liabilities
1.39M 1.18M 54K 36.04M
Total Long-Term Liabilities
1.57M 6.48M 1.53M 25.87M
Total Liabilities
15.42M 15.96M 26.21M 38.41M
Total Debt
6.43M 5.95M 12.77M 16.76M
Common Stock
3.06M 2.77M 1.88M 1.75M
Retained Earnings
-462.88M -419.63M -331.16M -296.97M
Comprehensive Income
-18.85M -17.48M 137.91M 136.9M
Shareholders Equity
60.97M 50.54M 61.87M 88M
Total Investments
n/a n/a 51.1M 569K